Skip to content
Boost Up Blog – Lifestyle
Author:
Nanobiotix S.A.
Voting Rights and Shares Capital of the Company
April 7, 2026
NANOBIOTIX Provides Business Update and Reports Full Year 2025 Financial Results
April 1, 2026
NANOBIOTIX Announces Presentation of First Data from a Randomized Phase 2 Clinical Trial Evaluating JNJ-1900 (NBTXR3) in Stage 3 Inoperable Lung Cancer
March 30, 2026
NANOBIOTIX Statement Regarding Recent Media Speculation
March 25, 2026
Voting Rights and Shares Capital of the Company
March 12, 2026
←
Previous Page
1
2